title: Clinical experience with the addition of pramlintide in patients with insulin-requiring type 2 diabetes.
authors.affiliation: Metabolic Center of Louisiana Research Foundation, 7566 Picardy Ave., Baton Rouge, LA 70808, USA. karen.elkind-hirsch@womans.org
authors.forename: Karen
authors.initials: K
authors.lastname: Elkind-Hirsch
authors.forename: William J
authors.initials: WJ
authors.lastname: Butler
authors.forename: Madhu
authors.initials: M
authors.lastname: Bhushan
authors.forename: David
authors.initials: D
authors.lastname: Hirsch
authors.forename: Rajat
authors.initials: R
authors.lastname: Bhushan
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000682:Amyloid / Q000627:therapeutic use*; D001786:Blood Glucose / Q000187:drug effects / Q000378:metabolism; D001823:Body Composition; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D006442:Glycated Hemoglobin / Q000378:metabolism; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D007328:Insulin / Q000627:therapeutic use*; D058228:Islet Amyloid Polypeptide; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies
chemical_list: D000682:Amyloid; D001786:Blood Glucose; D006442:Glycated Hemoglobin; D007004:Hypoglycemic Agents; D007328:Insulin; D058228:Islet Amyloid Polypeptide; C105254:pramlintide